211 related articles for article (PubMed ID: 12579992)
21. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma.
McCluggage WG; Catherwood M; Alexander HD; McBride HA; Smith ME; Morris TC
Histopathology; 2002 Nov; 41(5):414-20. PubMed ID: 12405909
[TBL] [Abstract][Full Text] [Related]
23. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
[TBL] [Abstract][Full Text] [Related]
24. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
[TBL] [Abstract][Full Text] [Related]
26. Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma.
Lee JC; Hoehn D; Schecter J; Murty VV; Mansukhani MM; Alobeid B; Bhagat G
Hum Pathol; 2013 Jul; 44(7):1328-40. PubMed ID: 23363648
[TBL] [Abstract][Full Text] [Related]
27. Mantle cell lymphoma with aberrant expression of CD10.
Zanetto U; Dong H; Huang Y; Zhang K; Narbaitz M; Sapia S; Kostopoulos I; Liu H; Du MQ; Bacon CM
Histopathology; 2008 Jul; 53(1):20-9. PubMed ID: 18518902
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas.
Kim BK; Surti U; Pandya A; Cohen J; Rabkin MS; Swerdlow SH
Am J Surg Pathol; 2005 Jan; 29(1):69-82. PubMed ID: 15613857
[TBL] [Abstract][Full Text] [Related]
29. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
30. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas.
Bai M; Agnantis NJ; Skyrlas A; Tsanou E; Kamina S; Galani V; Kanavaros P
Mod Pathol; 2003 May; 16(5):471-80. PubMed ID: 12748254
[TBL] [Abstract][Full Text] [Related]
32. Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers.
Chiu KC; Fine M; Ikle D; Slovak ML; Arber DA
Hum Pathol; 2003 Dec; 34(12):1259-64. PubMed ID: 14691911
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma.
Ma XB; Zhong YP; Zheng Y; Jiang J; Wang YP
Cancer Med; 2018 Sep; 7(9):4284-4295. PubMed ID: 30019388
[TBL] [Abstract][Full Text] [Related]
34. [Gastrointestinal B-cell lymphoma: a morphologic and immunohistochemical study of 194 cases].
He S; Guo Y; Bei CF; Dai YZ; Zhu DB; Li CS; Zhu XH; LE MZ
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):814-8. PubMed ID: 21215096
[TBL] [Abstract][Full Text] [Related]
35. [Pathologic characteristics of bone marrow for
CD5 positive small B cell lymphoma].
Peng S; Zhu F; You S; Gong M; Wen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):374-9. PubMed ID: 27241147
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity.
Yatabe Y; Nakamura S; Seto M; Kuroda H; Kagami Y; Suzuki R; Ogura M; Kojima M; Koshikawa T; Ueda R; Suchi T
Am J Surg Pathol; 1996 Sep; 20(9):1110-22. PubMed ID: 8764748
[TBL] [Abstract][Full Text] [Related]
38. The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas.
Wu JM; Borowitz MJ; Weir EG
Am J Clin Pathol; 2006 Jul; 126(1):39-46. PubMed ID: 16753591
[TBL] [Abstract][Full Text] [Related]
39. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
[TBL] [Abstract][Full Text] [Related]
40. Antigen preservation in infarcted nodal B-cell lymphoma, with special reference to follicular center cell markers.
Kojima M; Nakamura S; Yamane Y; Nishikawa M; Murayama K; Shimizu K; Itoh H; Masawa N
Int J Surg Pathol; 2004 Jul; 12(3):251-5. PubMed ID: 15306937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
